Human T-cell lymphotropic virus type I (HTLV-I)-infected T-cell clones ente
r the S-phase of the cell cycle in the absence of exogenous IL-2. The pathw
ay by which HTLV-I activates the host T cell may circumvent normal immunore
gulatory mechanisms and thus be important for the pathogenesis of HTLV-I-in
duced diseases. The early control of viral infections is in part mediated b
y interferons (IFNs), which possess both antiviral and antiproliferative fu
nctions. In order to investigate the antiproliferative effect of IFN-beta o
n HTLV-l-induced T-cell activation, we generated T-cell clones from patient
s with HTLV-I-associated myelopathy/tropical spastic paraparesis by single-
cell cloning under limiting dilution conditions. Here we demonstrate that H
TLV-l-induced T-cell proliferation is resistant to the antiproliferative ac
tion of IFN-beta. Moreover, HTLV-I-infected T-cell clones continue to const
itutively secrete IFN-gamma in the presence of high doses of IFN-beta. HTLV
-l-infected T cells express normal levels of IFNAR1 and are able to respond
to IFN-beta by phosphorylation of STAT1 on Tyr(701), although they display
a relative increase in phosphorylation of the transcriptionally inactive S
TAT1 beta when compared with STAT1 alpha. Thus, HTLV-I promotes cell cycle
progression in G(1) by a mechanism that overcomes inhibitory signals, there
by circumventing an innate immune defense mechanism. (C) 1999 Academic Pres
s.